Using antagomir-150, a chemically stabilized miR-150 inhibitor, markedly inhibited control cells; while silencing EPG5 attenuated the anti-tumor effect of antagomir-150 in shEPG5 cells in vitro (Figure 5E). The gene discussed is EPG5; the disease is neoplasm.